Molecular genetics of familial hypercholesterolemia in Norway

Journal of Internal Medicine

Volumn 241, Issue 3, 1997, Pages 185-193

  Leren, T P ^a   Tonstad, S ^b   Gundersen, K E ^a   Bakken, K S ^a   Rodningen O K ^a   Sundvold, H ^a   Ose, L ^b   Berg, K ^a,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

apolipoprotein B; familial hypercholesterolemia; low density lipoprotein receptor; mutations

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENETIC ANALYSIS; HUMAN; MALE; MOLECULAR GENETICS; MUTATION; NORWAY; PRIORITY JOURNAL;

EID: 0030936470     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.78119000.x     Document Type: Article

References (48)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hyper-cholesterolemia. In: Scriver CR, Baudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease, 7th edn. New York: McGraw-Hill Book Co, 1995; 1981-2030.
2. Müller C. Angina pectoris in hereditary xanthomatosis. Arch Intern Med 1939; 64: 675-700.
3. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544-68.
4. Slack J. Inheritance of familial hypercholesterolemia. In: Paoletti R, Gotto AM, eds. Atheroscl Review Vol. 5. New York: Raven Press, 1979: 35-66.
5. Williams RR, Hamilton-Craig I, Kostner GM, Hegele RA, Hayden MR. Pimstone SN et al. MED PED: An integrated genetic strategy for preventing early deaths. In: Berg K, Boulyjenkov V, Christen Y, eds. Genetic Approaches to Noncommunicable Diseases. Berlin: Springer Verlag-Berlin, 1996; 35-46.
6. Illingworth DR. Drug therapy of hypercholesterolemia. Clin Chem 1988; 34: 123-32.
7. Leren TP, Hjermann I, Berg K, Leren P, Foss OP, Viksmoen L. Effect of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia. Atherosclerosis 1988; 73: 135-41.
8. Südhof TC, Goldstein JL, Brown MS, Russell DW. The LDL receptor gene: a mosaic of exons shared with different proteins. Science 1985; 228: 815-22.
9. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1: 445-66.
10. Orita M. Iwahana H, Kanazawa H. Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-70.
11. Leren TP, Solberg K. Rodningen OK, Ose L, Tonstad S, Berg K. Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene. PCR Meth Appl 1993; 3: 159-62.
12. Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH. Common lowdensity lipoprotein receptor mutations in the French Canadian population. J Clin Invest 1990; 85: 1014-23.
13. Leren TP, Rødningen OK, Røsby O, Solberg K, Berg K. Screening for point mutations by semi-automated DNA sequencing using Sequenase and magnetic beads. Biotechniques 1993; 14: 618-23.
14. Leren TP, Sundvold H. Rødningen OK, Tonstad S, Solberg K, Ose L. Screening for known mutations in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects. Hum Genet 1995; 95: 671-6.
15. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 1989; 86: 587-91
16. Hansen PS, Rüdiger N, Tybjærg-Hansen A, Færgeman O, Gregersen N. Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with Mspl. J Lipid Res 1991; 32: 1229-33.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
18. Siervogel RM, Morrison, JA, Kelly K, Mellies M, Gartside P, Glueck CJ. Familial hyper-alpha-lipoproteinemia in 26 kindreds. Clin Genet 1980; 17: 13-25.
19. Kotze MJ, Langenhoven E, Warnich L, du Plessis L, Marx MP, Oosthuizen CJJ, Retief AE. The identification of two lowdensity lipoprotein receptor gene mutations in South African familial hypercholesterolemia. S Afr Med J 1989; 76: 399-401.
20. Koivisto UM, Viikari JS, Kontula K. Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: Identification of two common missense mutations (Gly823 → Asp and Leu 380 → His) and eight rare mutations of the LDL receptor gene. Am J Hum Genet 1995; 57: 789-97.
21. Yamamoto T, Davis CG, Brown MS, Schneider WJ, Casey ML, Goldstein JL, Russell DW. The human LDL receptor: a cysteinerich protein with multiple Alu sequences in its m-RNA. Cell 1984; 39: 27-38.
22. Statistics Norway. Statistical Yearbook, 114 edn. Oslo: Statistics Norway. 1995.
23. Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L. Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis 1994; 111: 175-82.
24. Gundersen KE, Solberg K, Rødningen OK, Tonstad S, Ose L, Berg K, Leren TP. Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia. Clin Genet 1996; 49: 85-7.
25. Sundvold H, Solberg K, Tonstad. S, Rodningen OK, Ose L, Berg K, Leren TP. A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects. Hum Mutat 1996; 7: 70-71.
26. Solberg K, Rodningen OK, Tonstad S, Ose L, Leren TP. Familial hypercholesterolemia caused by a non-sense mutation in codon 329 of the LDL receptor gene. Scand J Clin Lab Invest 1994; 54: 605-9.
27. Leren TP, Solberg K, Tonstad S, Ose L. Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia. Hum Genet 1995; 96: 241-2.
28. Soutar AK, Knight BL, Patel DD. Identification of a point mutation in growth factor repeat of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors. Proc Natl Acad Sci USA 1989; 86: 4166-70.
29. Aalto-Setälä K, Helve E, Kovanen PT, Kontula K. Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype. J Clin Invest 1989; 84: 499-505.
30. Miserez AR, Laager R, Chiodetti N, Keller U. High prevalence of familial defective apolipoprotein B-100 in Switzerland. J Lipid Res 1994; 35: 574-83.
31. Myant NB. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolemia. Atherosclerosis 1993; 104: 1-18.
32. Miserez AR, Keller U. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Arterioscl Thromb 1995; 15: 1719-29.
33. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Hum Mutat 1993; 2: 404-14.
34. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993; 16: 325-32.
35. Rødningen OK, Røsby O, Tonstad S, Ose L, Berg K, Leren TP. A 9.6 kb deletion in the low density lipoprotein receptor gene in Norwegian familial hypercholesterolemia subjects. Clin Genet 1992; 42: 288-95.
36. Bertolini S, Garuti R, Lelli W, Rolleri M, Tiozzo RM. Ghisellini M et al. Four novel partial deletions of LDL-receptor gene in Italian patients with familial hypercholesterolemia. Arterioscl Thromb 1995; 15: 81-8.
37. Sun X-M, Webb JC, Gudnason V, Humphries S, Seed M, Thompson GR et al. Characterization of deletions in the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom. Arterioscl Thromb 1992; 12: 762-70.
38. Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet 1988; 78: 151-5.
39. Sun X-M, Patel DD, Bhatnagar D, Knight BL, Soutar AK. Characterization of a splice-site mutation in the gene for the LDL receptor associated with an unpredictable severe clinical phenotype in English patients with heterozygous FH. Arterioscler Thromb 1995; 15: 219-27.
40. Jensen HK, Jensen LG, Meinertz H, Hansen PS, Færgeman O, Gregersen N. Familial hyeprcholesterolemia in Denmark: A mutational analysis of the LDLR gene. Abstract at 65th meeting of the European Atherosclerosis Society. Aarhus September 28-October 1, 1995.
41. Lombardi P, Sijbrands EJG, Giessen Kvd, Smelt AHM, Kastelein JJP, Frants RR, Havekes LM. Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gel electrophoresis and direct sequencing. J Lipid Res 1995; 36: 860-67.
42. Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. New Engl J Med 1987; 317: 734-7.
43. Ma Y, Betard C, Roy M, Davignon J, Kessling AM. Identification of a second 'French Canadian' LDL receptor gene deletion and development of a rapid method to detect both deletions, Clin Genet 1989; 36: 219-28.
44. Kotze MJ, Langenhoven E, Warnich L, Du Plessis L. Retief AE. The molecular basis and diagnosis of familial hypercholesterolemia in South African Afrikaners Ann Hum Genet 1991; 55: 115-21.
45. Lehrman MA, Schneider WJ, Brown MS, Davis CG, Elhammer A, Russell DW, Goldstein JL. The Lebanese allele at the low density lipoprotein locus. Nonsense mutation produces truncated receptor that is retained in endoplasmatic reticulum. J Biol Chem 1987; 262: 401-10.
46. Aalto-Setälä K, Koivisto U-M, Miettinen TA, Gylling H, Kesäniemi YA, Savolainen M et al. Prevalence and geographical distribution of major LDL receptor gene arrangements in Finland. J Intern Med 1992; 231: 227-34.
47. Koivisto U-M, Turtola H, Aalto-Setälä K, Top B, Frants RR, Kovanen PT et al. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland. J Clin Invest 1992; 90: 219-28.
48. Heiberg A, Berg K. The inheritance of hyperlipoproteinemia with xanthomatosis. A study of 132 kindreds. Clin Genet 1976; 9: 203-33.